Not Tagged
Not Tagged
['biomarker', 'lcsm,(-blcsm)', 'sclc']
advancing outcomes in sclc remains a big challenge. tigit is not it not every sclc patient is the same. we need to think of subtypes/biomarkers in sclc trial design #asco2022 #lcsm 
MD MSc, Thoracic Oncology & Respiratory Medicine, master in hospital and health care management Hasselt - Belgium - PhD candidate LUMC Leiden - he/him